Sažetak
Background: Breast cancer surgery induces substantial physiological stress that disrupts endocrine regulation and triggers systemic inflammation. However, the biochemical dynamics underlying these perioperative alterations remain insufficiently characterized. This study investigated laboratory-based endocrine and inflammatory biomarker changes following breast cancer surgery and explored their clinical significance.
Methods: A total of 120 breast cancer patients were evaluated. Serum estradiol (E2), progesterone (P), interleukin-6 (IL-6), C-reactive protein (CRP), and tumor necrosis factor-α (TNF-α) were measured preoperatively and on postoperative day 7 using validated ELISA assays with strict analytical quality control. Clinical outcomes—including psychological status, cognitive recovery, quality of life, and postoperative complications—were assessed as secondary indicators to explore potential biochemical–clinical associations.
Results: Postoperative endocrine suppression was evident, with significant reductions in E2 and P levels (P < 0.05), reflecting acute stress–related modulation of hypothalamic–pituitary–gonadal (HPG) axis activity. IL-6, CRP, and TNF-α declined significantly postoperatively (all P < 0.001), demonstrating resolution of acute-phase inflammatory activation. Greater biochemical stabilization was associated with improved emotional scores, cognitive function, and quality-of-life indices, as well as a reduced incidence of postoperative complications.
Conclusion: Breast cancer surgery induces characteristic biochemical changes involving endocrine suppression and systemic inflammatory activation. Monitoring hormonal and inflammatory biomarkers provides valuable insight into postoperative physiological stress, recovery mechanisms, and potential risk stratification. These findings support integrating laboratory-based biochemical assessments into postoperative management frameworks for breast cancer patients.
Ključne reči
Array
Array
Array
Array
Array
Array
Array
Reference
The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.